Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens

NCT01814722 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.

NCT NCT01814722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01814722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life of HIV-infected Patients Switched to Raltegravir Versus Other Antiretroviral Regimens
Lead sponsor
Merck Sharp & Dohme LLC
Phase
Observational
Overall status
Terminated
Start date
November 9, 2012
Completion date
October 31, 2013
Enrollment
63 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus